Treatment of chorea associated with Huntington's disease: Focus on tetrabenazine

Stephen M. Setter, Joshua J. Neumiller, Erin K. Dobbins, Lindy Wood, Jeffrey Clark, Cristina A.K. DuVall, Anthony J Santiago

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Objective: Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ. Data Sources: Literature identified within MEDLINE and PubMED. Study Selection: Two manuscripts specifically regarding the management of chorea in patients with HD were identified. Additionally, studies involving the clinical use of TBZ were reviewed. Data Synthesis: The literature identified provided information regarding the efficacy, safety, and pharmacological actions of TBZ. Conclusion: HD is often accompanied by chorea, and the treatment with TBZ in this patient population often results in decreased chorea. Pharmacists managing patients on TBZ need to be well versed in TBZ's potential side effects, drug interactions, and unique dosing considerations.

Original languageEnglish (US)
Pages (from-to)524-537
Number of pages14
JournalConsultant Pharmacist
Issue number7
StatePublished - Jul 2009


  • Chorea
  • Huntington's disease
  • Tetrabenazine


Dive into the research topics of 'Treatment of chorea associated with Huntington's disease: Focus on tetrabenazine'. Together they form a unique fingerprint.

Cite this